GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 10th May 2013 07:14

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation.Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral.Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating unchanged. Deutsche Bank shifts target price from 323p to 336p and reiterates a buy recommendation.British Sky Broadcasting Group: Bank of America cuts target price from 670p to 650p and reiterates an underperform rating.Britvic: Deutsche Bank raises target price from 425p to 460p and retains a hold recommendation.BT Group: Bank of America takes target price from 275p to 325p and upgrades to buy.Clarke T: Panmure Gordon moves target price from 40p to 58p and upgrades from hold to buy.Derwent London: Morgan Stanley increases target price from 2220p to 2450p and upgrades to overweight.e-Therapeutics: Panmure Gordon shifts target price from 72p to 67p keeping its buy recommendation.Experian: Citigroup raises target price from 1320p to 1410p and maintains a buy recommendation. Deutsche Bank downgrades to hold with a target price of 529p.Greencore: Investec shifts target price from 125p to 130p and maintains a buy recommendation. Panmure Gordon takes target price from 110p to 125p retaining its buy recommendation.Inchcape: HSBC Holdings initiates with a target price of 640p and an overweight rating.InterContinental Hotels Group: JP Morgan lowers target price from 1950p to 1920p and reiterates a neutral rating.London Mining: JP Morgan moves target price from 215p to 205p and maintains an overweight rating.Lonmin: Exane BNP lowers target price from 270p to 260p staying with its neutral rating.Morrison (Wm): Nomura ups target price from 270p to 310p keeping a neutral rating.National Grid: JP Morgan moves target price from 730p to 785p and retains a neutral rating.Ocado Group: Goldman Sachs upgrades to buy with its target price at 300p. Panmure Gordon raises target price from 50p to 130p, but still recommends selling.Portmeirion: Panmure Gordon takes target price from 657p to 694p reiterating its buy recommendation.Restaurant Group: Panmure Gordon increases target price from 435p to 560p and keeps a buy recommendation.Rightmove: Panmure Gordon ups target price from 2000p to 2300p and leaves its buy recommendation unchanged.RPC Group: JP Morgan reduces target price from 512p to 491p and stays with its overweight rating.Sage Group: Exane BNP shifts target price from 235p to 240p and leaves its underperform rating unaltered.SIG: JP Morgan raises target price from 95p to 135p, while maintaining an underweight rating.St Modwen Properties: JP Morgan increases target price from 290p to 320p staying with its overweight rating.Travis Perkins: JP Morgan ups target price from 999p to 1380p, while its neutral rating remains unchanged. Panmure Gordon downgrades from buy to hold with a target price of 1350p.TUI Travel: Numis ups target price from 350p to 375p and reiterates an add rating. Panmure Gordon moves target price from 303p to 315p, while its hold recommendation is reiterated.Restaurant Group: Citigroup downgrades to neutral with a target price of 500p.Royal Bank of Scotland: Citigroup lowers target price from 300p to 290p keeping a neutral rating.Wetherspoon (JD): Deutsche Bank takes target price from 490p to 520p and maintains a hold recommendation. Panmure Gordon increases target price from 615p to 738p retaining a buy recommendation.
More News
16 Oct 2013 11:57

UK WINNERS & LOSERS: Hargreaves Continues To Rise, e-Therapeutics Trips

Read more
16 Oct 2013 08:56

e-Therapeutics Pretax Loss Widens As R&D Expenditure Rises

Read more
30 Sep 2013 18:45

DIRECTOR DEALINGS: E-Therapeutics Exec, Wife Combined Shares Total 1.8M

Read more
24 Jul 2013 15:53

Wife of DS Smith CEO sells 5.6m-pound stake

The wife of DS Smith frontman Miles Roberts sold a substantial sum of shares in the packaging and office supplies firm on the same day it was revealed the Chief Executive Officer (CEO) received a big pay increase last year. The move came on Tuesday, the same day DS Smith released its annual report

Read more
14 May 2013 09:46

e-Therapeutics pleases with pipeline progress

News from biotech company e-Therapeutics about the progress of two clinical trials for its cancer drug pleased the markets on Tuesday. The AIM-listed company provided first findings for the company's ETS2101 drug candidate in Phase I trials in the US for patients with brain cancer and in the UK fo

Read more
14 May 2013 08:04

Tuesday broker round-up UPDATE

Babcock International: Jefferies increases target price from 1080p to 1250p and maintains a buy recommendation. Barratt Developments: Bank of America takes target price from 265p to 325p, while downgrading to neutral. Belgravium Technologies: WH Ireland places both its target price and its neutral

Read more
19 Feb 2013 16:21

Debenhams Executive Director adds to stake

Michael Sharp, the Executive Director of retail chain Debenhams, has topped up his stake in the group with the purchase of 50,000 shares. Sharp, who has been in his current role since September 2011, bought the shares at 97.20p for a total of £48,598. He now holds 6.2m shares in the company. Debe

Read more
11 Feb 2013 09:15

e-Therapeutics shares jump following 40m equity issue

Drug discovery and development company e-Therapeutics is proposing to raise 40m pounds through an issue of new ordinary shares to existing and new institutional investors. The new shares will be priced at 32p, a premium of 4.0% to the closing mid-market price on Friday. Following the proposed issu

Read more
23 Oct 2012 09:23

Tuesday broker round-up

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept. ARM Holdings: Investec keeps buy rating and 800p target. Avacta: Panmure Gordon keeps buy rating and 1.75p target. AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept. Babcock: JPMorgan Cazenove ups targe

Read more
22 Oct 2012 08:19

Monday broker round-up - UPDATE

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barcl

Read more
22 Oct 2012 07:53

e-therapeutics produces mixed interims

e-therapeutics, a drug discovery and development company, produced mixed interims with slightly increased losses, but reported progress on its lead cancer drug. As expected, first half losses increased to £1.8m (2011: loss of £1.5m), reflecting increased investment in the business. The company ha

Read more
15 Mar 2011 17:05

Bramson vehicle buys more shares in F&C

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appointed chairman of F&C last month after a shareholder coup removed the previous incumbent, along with another non-executive, and appointed three new di

Read more
14 Mar 2011 17:19

Wife of outgoing FD sells British Land shares

Diane Roberts, the wife of British Land finance director Graham Roberts, has raised more than £1m by selling more than three-quarters of the couple's stake in the property investor. She sold 191,780 shares at 562.8p each, which raised £1.08m. The couple are left with 50,464 shares in British Land.

Read more
4 Mar 2011 17:03

Shaftesbury boss invests £100,000

Shaftesbury chief executive Jonathan Lane has invested a further £100,000 in the property investor. Lane has bought 22,222 shares at 450p each. That takes his stake to 966,233 shares, which is worth £4.3m at the latest purchase price. Lane raised just over £99,000 from the sale of option shares la

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.